Develops systems designed to improve safety of blood transfusions by inactivating infectious pathogens in blood components, platelets, fresh frozen plasma and red blood cells, and to inhibit leukocyte activity. Details of system and company based in Concord, California. (Nasdaq: CERS).

Visits
9
Added
Mar 16, 2025
Rating
(150)
Rate This Site
QR Code
QR code Download PNG
Embed Badge
Place this code on your website to show you're listed here.
Advertise herefrom $15.00/day  ·  RON $21.00/day
Get the best links delivered weekly — hand-picked from 2,999,517 resources